SLNO · Soleno Therapeutics Inc
$53.01
+0.00 (+0.00%)
At close · May 18
Market Cap
$2.76B
Shares
52.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-18 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-04-07 | — | |
| 8-K | 2026-04-06 | 2026-04-05 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-02-26 | 2026-02-25 | |
| 8-K | 2026-02-25 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-01-23 | 2026-01-21 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-12 | 2025-11-10 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-10-14 | 2025-10-13 | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-08-18 | — | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-07-11 | 2025-07-10 | |
| 8-K | 2025-07-10 | — | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| DEF 14A | 2025-04-22 | 2025-06-05 | |
| 8-K | 2025-04-18 | 2025-04-17 | |
| 8-K | 2025-03-26 | — | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-24 | 2025-01-21 | |
| 8-K | 2024-12-17 | — | |
| 8-K | 2024-11-26 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-08-15 | 2024-08-09 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-07-19 | 2024-07-17 | |
| 8-K | 2024-07-19 | — | |
| 8-K | 2024-06-28 | — | |
| 8-K | 2024-06-20 | 2024-06-13 | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-05-10 | 2024-05-09 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-07 | 2024-05-02 | |
| 8-K | 2024-04-29 | — | |
| DEF 14A | 2024-04-22 | 2024-06-06 | |
| 8-K | 2024-04-22 | 2024-04-17 | |
| 8-K | 2024-03-07 | 2024-03-06 |
Showing 1–50 of 128 filings